OAR 333-018-0018: Submission of Organisms or Specimens to the Public Health Laboratory

Licensed laboratories are required to forward aliquots, specimens or cultures of the following organisms to the Oregon State Public Health Laboratory: (1) Select biological agents and toxins: Avian influenza virus; Bacillus anthracis; Botulinum neurotoxins; Botulinum neurotoxin producing species of Clostridium; Brucella abortus; Brucella melitensis; Brucella suis; Burkholderia mallei; Burkholderia pseudomallei; Conotoxin; Coxiella burnetii; Crimean-Congo hemorrhagic fever virus; Diacetoxyscirpenol; Eastern Equine Encephalitis virus; Ebola virus; Francisella tularensis; Hendra virus; Lassa fever virus; Lujo virus; Marburg virus; Monkeypox virus; Newcastle disease virus; Nipah virus; Reconstructed replication competent forms of the 1918 pandemic influenza virus containing any portion of the coding regions of all eight gene segments (Reconstructed 1918 Influenza virus); Ricin; Rickettsia prowazekii; Rift Valley fever virus; SARS-associated coronavirus (SARS-CoV), Saxitoxin; Sheep pox virus; South American Hemorrhagic Fever viruses (Chapare, Guanarito, Junin, Machupo, Sabia); Staphylococcal enterotoxins A,B,C,D,E subtypes; T-2 toxin, Tetrodotoxin; Tick-borne encephalitis complex (flavi) viruses (Far Eastern subtype; Siberian subtype); Kyasanur Forest disease virus; Omsk hemorrhagic fever virus; Variola major virus (Smallpox virus); Variola minor virus (Alastrim); Venezuelan equine encephalitis virus; and Yersinia pestis. (2) Other organisms or specimens including: (a) From persons of any age: (A) All isolates of Corynebacterium diphtheriae, Grimontia spp., Listeria spp., Mycobacterium tuberculosis and M. bovis, Salmonella spp., Shigella spp., Vibrio spp., and Yersinia spp. and suspected Shiga-toxigenic Escherichia coli (STEC), including E. coli O157; (B) All isolates of Acinetobacter species and Enterobacterales order bacteria resistant to any carbapenem antibiotic; (C) All isolates of any organism known to be carbapenemase-producing; (D) All isolates of suspected Neisseria meningitidis and Haemophilus influenzae from normally sterile sites; (E) All specimens that test positive by antigen-detection or nucleic acid testing for Listeria, Salmonella, Shigella, Vibrio, or Yersinia, for which culture has not been attempted; (F) All specimens that test positive by antigen-detection or nucleic acid testing for Shiga toxin, and from which Escherichia coli O157 has not been isolated. (G) All specimens that test positive for Measles (rubeola), poliomyelitis, rabies (human), rubella, yellow fever, and all novel and highly pathogenic avian influenza strains; (H) All specimens from normally sterile sites testing positive for Haemophilus influenzae or Neisseria meningitidis by non-culture methods; and (I) All isolates of Candida auris, Coccidioides spp., and Cryptococcus spp. (b) From persons under the age of 18 years who died with laboratory-confirmed influenza: respiratory specimens or viral isolates, any Staphylococcus aureus isolates, and, after consulting with the Oregon Public Health Division, autopsy specimens. (c) From infants under the age of one year: all isolates of Cronobacter sakazakii.